SMS Pharmaceuticals has informed that the Company has approved to provide security to Avendus Finance for and on behalf of VKT Pharma, Associate Company in the form of pledge of the Company's holding i.e., 38,50,165 equity shares consisting of 36.55% in VKT Pharma in addition to the other securities provided by VKT Pharma and its promoters, in relation to NonConvertible Debentures (NCDs) to be Issued by VKT Pharma to Avendus Finance for an aggregate amount of Rs 130 Crores, for a tenure of 54 months. Additional details pursuant to Regulation 30 read with Schedule 11/ Part-A of SEBI (LOOR) Regulations, 2015 enclosed as Annexure.
The above information is a part of company’s filings submitted to BSE.
